Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches. | Cancers (Basel) | 2023 | 37370855 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles as therapeutics of degenerative orthopedic diseases. | Front Bioeng Biotechnol | 2023 | 37362216 | PubTator, text mining | PubMed |
| Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. | Front Pharmacol | 2023 | 37361234 | PubTator, text mining | PubMed |
| COVID-19 off-label uses of medicines: the role of civil liability and regulation. | Geneva Pap Risk Insur Issues Pract | 2023 | 37359236 | PubTator, text mining | PubMed |
| Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages. | Cancers (Basel) | 2023 | 37345054 | PubTator, text mining | PubMed |
| Tuning orbital-selective phase transitions in a two-dimensional Hund's correlated system. | Nat Commun | 2023 | 37328474 | PubTator, text mining | PubMed |
| PLGA-based drug delivery systems in treating bone tumors. | Front Bioeng Biotechnol | 2023 | 37324432 | PubTator, text mining | PubMed |
| Protein salvage and repurposing in evolution: Phospholipase D toxins are stabilized by a remodeled scrap of a membrane association domain. | Protein Sci | 2023 | 37313620 | PubTator, text mining | PubMed |
| Network medicine framework identified drug-repurposing opportunities of pharmaco-active compounds of Angelica acutiloba (Siebold & Zucc.) Kitag. for skin aging. | Aging (Albany NY) | 2023 | 37310405 | PubTator, text mining | PubMed |
| Corrigendum to: Cap-independent translation of GPLD1 enhances markers of brain health in long-lived mutant and drug-treated mice. | Aging Cell | 2023 | 37307144 | PubTator, text mining | PubMed |
| Modelling spatiotemporal dynamics of cerebral blood flow using multiple-timepoint arterial spin labelling MRI. | Front Physiol | 2023 | 37304817 | PubTator, text mining | PubMed |
| Membrane Lipid Derivatives: Roles of Arachidonic Acid and Its Metabolites in Pancreatic Physiology and Pathophysiology. | Molecules | 2023 | 37298790 | PubTator, text mining | PubMed |
| Δ8-THC Induces Up-Regulation of Glutamatergic Pathway Genes in Differentiated SH-SY5Y: A Transcriptomic Study. | Int J Mol Sci | 2023 | 37298437 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression. | Cancers (Basel) | 2023 | 37296932 | PubTator, text mining | PubMed |
| Bio-enabled Engineering of Multifunctional "Living" Surfaces. | ACS Nano | 2023 | 37294942 | PubTator, text mining | PubMed |
| Membrane trafficking in breast cancer progression: protein kinase D comes into play. | Front Cell Dev Biol | 2023 | 37293129 | PubTator, text mining | PubMed |
| Genome organization and genomics in Chlamydia: whole genome sequencing increases understanding of chlamydial virulence, evolution, and phylogeny. | Front Cell Infect Microbiol | 2023 | 37287464 | PubTator, text mining | PubMed |
| Active Gains in brain Using Exercise During Aging (AGUEDA): protocol for a randomized controlled trial. | Front Hum Neurosci | 2023 | 37284481 | PubTator, text mining | PubMed |
| Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma. | Front Immunol | 2023 | 37275878 | PubTator, text mining | PubMed |
| Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report. | Front Endocrinol (Lausanne) | 2023 | 37274321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=18